Oberweis Asset Management Inc Organogenesis Holdings Inc. Transaction History

Oberweis Asset Management Inc

  • $1.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$9.02 - $13.5 $4.59 Million - $6.87 Million
-509,058 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$13.71 - $17.18 $720,460 - $902,809
-52,550 Reduced 9.36%
509,058 $7.25 Million
Q2 2021

Aug 16, 2021
BUY
$14.92 - $23.23 $1.11 Million - $1.72 Million
74,188 Added 15.22%
561,608 $9.33 Million
Q1 2021

May 17, 2021
BUY
$7.33 - $21.06 $3.57 Million - $10.3 Million
487,420 New
487,420 $8.88 Million

Others Institutions Holding ORGO

# of Institutions
117
Shares Held
63.2M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email